1-4 of 4
Adnan Mansoor, MD, FCPS, FRCP(C), FCAP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A miRNA Risk Score for the Prediction of Response to Lenalidomide in Multiple Myeloma (MM) Patients

Paola Neri, MD, PhD, Andrew R Belch, MD, Jordan Johnson, Kathy J Gratton, Li Ren, PhD, Peter Duggan, MD, FRCPC, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Douglas A. Stewart, MD, FRCP, Nizar Bahlis, MD
Journal: Blood
Blood (2011) 118 (21): 987.
https://doi.org/10.1182/blood.V118.21.987.987
Published: 2011
Journal Articles

High Herpesvirus-Specific T Cell Counts Are Associated with near-Zero Likelihood of Malignancy Relapse and a Low Likelihood of Infections Due to Any pathogen.

Mette Hoegh-Petersen, MD, Sarah Sy, Alejandra Ugarte-Torres, Tyler S Williamson, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Yiping Liu, Stephanie Liu, Kevin Fonseca, Faisal Khan, James A Russell, Jan Storek, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1285.
https://doi.org/10.1182/blood.V116.21.1285.1285
Published: 2010
Journal Articles

A miRNA Risk Score for the Prediction of Response to Rituximab-CHOP Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma

Nizar J Bahlis, MD, Carolyn J Owen, MD, FRCPC, Paola Neri, MD, PhD, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Kathy J Gratton, Peter Duggan, MD, FRCPC, Pietro Ravani, MD, PhD, Douglas A. Stewart, MD, FRCP
Journal: Blood
Blood (2010) 116 (21): 324.
https://doi.org/10.1182/blood.V116.21.324.324
Published: 2010
Journal Articles

Bortezomib Induced BRCAness Sensitizes Multiple Myeloma Cells to PARP Inhibitors

Paola Neri, MD, PhD, Li Ren, PhD, Kathy Gratton, Erin Stebner, Carolyn J Owen, MD, FRCPC, Peter Duggan, MD, FRCPC, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Douglas A. Stewart, MD, FRCP, Nizar J Bahlis, MD
Journal: Blood
Blood (2010) 116 (21): 789.
https://doi.org/10.1182/blood.V116.21.789.789
Published: 2010